Antiviral Chemotherapy 4
New Directions for Clinical Application and Research
The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of dr…
Mehr
CHF 197.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V103:
Folgt in ca. 5 Arbeitstagen
Produktdetails
Weitere Autoren: Mills, John (Hrsg.) / Volberding, Paul A. (Hrsg.)
- ISBN: 978-1-4757-9211-9
- EAN: 9781475792119
- Produktnummer: 15411630
- Verlag: Springer Us
- Sprache: Englisch
- Erscheinungsjahr: 2013
- Seitenangabe: 456 S.
- Masse: H23.5 cm x B15.5 cm x D2.4 cm 686 g
- Auflage: Softcover reprint of the original 1st ed. 1996
- Abbildungen: Paperback
- Gewicht: 686
5 weitere Werke von Lawrence (Hrsg.) Corey:
Bewertungen
Anmelden